Technology | Advanced Visualization | June 13, 2019

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite

Introductory product workflow Mimics Enlight Mitral provides support for transcatheter mitral valve replacements

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite

June 13, 2019 — Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug Administration (FDA) clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.

Mimics Enlight is based on the strengths of Materialise's Mimics Innovation Suite, which helps clinicians produce patient-specific 3-D models. Created in collaboration with Henry Ford Health System in Detroit with Dee Dee Wang, M.D., FACC, director of structural heart imaging, and leveraging the Henry Ford Innovation Institute's patented workflow, Mimics Enlight is intended to support patient selection and planning for structural heart and vascular therapy. The software is the first of its kind to include consistent methods of taking critical measurements, according to Materialise. This enables clinicians to reliably plan and screen patients for cardiovascular procedures. The TMVR workflow provides a streamlined, easy-to-use clinical workflow for planning complex procedures to correct mitral regurgitation, a disease affecting nearly one in 10 people age 75 and older.

Watch the VIDEO: Applications for 3-D Printing and Computer Aided Design in Cardiology, an interview with Wang.

Each mitral valve replacement differs due to a patient's unique anatomy, making procedural planning crucial to the successful implantation of TMVR devices. Accurate measurements during planning are vital for predicting patients' risk for left ventricular outflow tract (LVOT) obstruction, a complication resulting in obstruction of blood flow out of the left ventricle to the rest of the body.

Mimics Enlight Mitral gives clinicians accurate 3-D models for consistency in taking measurements like neo-LVOT to screen patients for TMVR therapy, plan procedures, and determine the appropriate size and positioning of TMVR devices.

Attendees can learn more about the Mimics Enlight Software from the Materialise medical team at the Transcatheter Valve Therapies (TVT) 2019 - Structural Heart Summit, June 13-15 in Chicago.

Read the article "The Use of 3-D Printing in Cardiology"

For more information: www.materialise.com

Related Content

 CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
News | Virtual and Augmented Reality | November 27, 2019
November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and m
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.
This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

News | Clinical Trials | November 08, 2019
November 8, 2019 — As the outbreak of lung injuries and deaths associated with e-cigarettes, or...
LungPrint Discovery offers fully automatic radiological metrics and unique, time-saving airway visualizations
News | Advanced Visualization | October 29, 2019
October 29, 2019 — VIDA Diagnostics, Inc.
The Konica Minolta Sonimage HS1 hand-carried system is designed for point of care ultrasound (POCUS) use for an immediate, quick look inside the patient. POCUS systems from several vendors are seeing rapid growth.

The Konica Minolta Sonimage HS1 hand-carried system is designed for point of care ultrasound (POCUS) use for an immediate, quick look inside the patient. POCUS systems from several vendors are seeing rapid growth.

Feature | Ultrasound Imaging | October 24, 2019 | Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability, and greater
Greater Left Ventricular Mass Increases Risk of Heart Failure
News | Cardiac Imaging | October 21, 2019
Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery...
USF Health Expands Digisonics System With Vascular Reporting
News | Cardiac PACS | October 17, 2019
University of South Florida (USF) Health in Tampa, Fla., has enhanced their use of the Digisonics Cardiovascular...
FDA Clears Modules of AI-Rad Companion Chest CT From Siemens Healthineers
Technology | Computed Tomography (CT) | September 26, 2019
The U.S. Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent...